Baudax Bio announces distribution of Series C Preferred Stock
PremiumThe FlyBaudax Bio announces distribution of Series C Preferred Stock
1y ago
Baudax Bio announces $1.9M registered direct offering
Premium
The Fly
Baudax Bio announces $1.9M registered direct offering
1y ago
Baudax Bio reports Q2 EPS ($1.51) vs ($41.95) last year
Premium
The Fly
Baudax Bio reports Q2 EPS ($1.51) vs ($41.95) last year
1y ago
Baudax Bio prices $4.0M public offering at $1.15 per share
PremiumThe FlyBaudax Bio prices $4.0M public offering at $1.15 per share
2y ago
Baudax Bio Soars after Positive Topline Data
Premium
Market News
Baudax Bio Soars after Positive Topline Data
2y ago
Baudax Bio says BX1000 met primary endpoint in Phase 2 trial
Premium
The Fly
Baudax Bio says BX1000 met primary endpoint in Phase 2 trial
2y ago
Baudax Bio Soars on Promising Phase 2 Data for BX1000
PremiumMarket NewsBaudax Bio Soars on Promising Phase 2 Data for BX1000
2y ago
Baudax Bio announces interim analysis outcome of Phase II trial of BX1000
Premium
The Fly
Baudax Bio announces interim analysis outcome of Phase II trial of BX1000
2y ago
Baudax Bio stops Anjeso sales, evaluating monetization approaches
Premium
The Fly
Baudax Bio stops Anjeso sales, evaluating monetization approaches
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100